EGFR and cutaneous squamous cell carcinoma: For example, Commandeur et al. established 3D in vitro models of normal skin and human cutaneous squamous cell carcinoma (SCC) to study the molecular mechanisms of carcinoma progression through either activation or inhibition of the epidermal growth factor receptor (EGFR) [32].